Free shipping on all orders over $ 500

YM-341619

Cat. No. M31278

All AbMole products are for research use only, cannot be used for human consumption.

YM-341619 Structure
Synonym:

AS1617612

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

YM-341619 (AS1617612) is a potent, orally active STAT6 inhibitor with an IC50 value of 0.70 nM. It can be used in studies related to allergic diseases (e.g., asthma and atopic rhinitis) by selectively inhibiting the differentiation of CD4(+) T cells into the Th2 subpopulation, and thereby inhibiting the ability to inhibit allergen-induced Th2 responses.

Chemical Information
Molecular Weight 458.45
Formula C22H21F3N6O2
CAS Number 643082-52-4
Form Solid
Solubility (25°C) DMSO 50 mg/mL
Storage -20°C
References

[1] Ibrahim Sulaiman, et al. Pulm Pharmacol Ther. Molecularly targeted therapies for asthma: Current development, challenges and potential clinical translation

[2] Keiko Ohga, et al. Eur J Pharmacol. YM-341619 suppresses the differentiation of spleen T cells into Th2 cells in vitro, eosinophilia, and airway hyperresponsiveness in rat allergic models

[3] Shinya Nagashima, et al. Bioorg Med Chem. Identification of 4-benzylamino-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5-carboxamide derivatives as potent and orally bioavailable STAT6 inhibitors

Related STAT Products
HP590 

HP590 is an orally active, novel and potent STAT3 inhibitor (STAT3 luciferase activity: IC50=27.8 nM; ATP inhibition: IC50=24.7 nM).

1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(4-(4-cyanophenoxy)phenyl)urea 

STAT3-IN-7 is a Sorafenib analogue and potently inhibits the phosphorylation of STAT3.

HJC0123

HJC0123 is a novel STAT3 inhibitor that suppresses the fibrogenic properties of HSCs. HJC0123 reduced the phosphorylation, nuclear translocation, and transcriptional activity of STAT3. HJC0123 treatment resulted in the inhibition of HSCs proliferation at submicromolar concentrations. It decreased the expression of STAT3-regulated proteins, induced cell cycle arrest, promoted apoptosis and downregulated SOCS3.

ODZ10117

ODZ10117 is a small molecule inhibitor of STAT3. ODZ10117 inhibited migration and invasion and induced apoptotic cell death by targeting STAT3 in glioblastoma cells.

OPB-111077

OPB-111077 is a first-in-class, novel, oral inhibitor of STAT3 and mitochondrial oxidative phosphorylation (OXPHOS) with anticancer activity. OPB-111077 inhibits mitochondrial respiratory chain complex I, which leads to inhibition of energy production and activation of the AMPK-mTOR energy stress sensor pathway.

  Catalog
Abmole Inhibitor Catalog




Keywords: YM-341619, AS1617612 supplier, STAT, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.